Cleared Traditional

K883305 - BINAX FSH IRMA TEST KIT, IMMUNORADIOMETRIC ASSAY

K883305 is an FDA 510(k) clearance for BINAX FSH IRMA TEST KIT, manufactured by Binax, Inc.. The device is a Class 1 Chemistry device with product code CGJ cleared through the Traditional 510(k) pathway after a 63-day FDA review.

K883305 · Binax, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1988
Decision
63d
Days
Class 1
Risk

K883305 is an FDA 510(k) clearance for the BINAX FSH IRMA TEST KIT, IMMUNORADIOMETRIC ASSAY. Classified as Radioimmunoassay, Follicle-stimulating Hormone (product code CGJ), Class I - General Controls.

Submitted by Binax, Inc. (S. Portland, US). The FDA issued a Cleared decision on October 6, 1988 after a review of 63 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1300 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Binax, Inc. devices

FDA 510(k) Submission Details - K883305

510(k) Number K883305 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 04, 1988
Decision Date October 06, 1988
Days to Decision 63 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
25d faster than avg
Panel avg: 88d · This submission: 63d
Pathway characteristics
Predicate-based equivalence.

CGJ Device Classification - Class 1, General Controls

Product Code CGJ Radioimmunoassay, Follicle-stimulating Hormone
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1300
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CGJ Radioimmunoassay, Follicle-stimulating Hormone

All 67
Devices cleared under the same product code (CGJ) and FDA review panel - the closest regulatory comparables to K883305.
FIAGEN HFSH TIME-RESOLVED FLUOROIMMUNOASSAY KIT
K884708 · Cyberfluor, Inc. · Jan 1989
CIBA CORNING MAGIC LITE FSH IMMUNOASSAY
K884687 · Ciba Corning Diagnostics Corp. · Dec 1988
IRMA-COUNT(TM) FSH W/MONOCLONAL ANTIBODIES
K883745 · Diagnostic Products Corp. · Nov 1988
PHASE II FSH KIT
K883279 · Vitek Systems, Inc. · Sep 1988
AMERLITE FSH ASSAY, LAN.0077/2077 240 AND 144 TEST
K881142 · Amersham Corp. · Jul 1988
FSH ENZYME IMMUNOASSAY TEST KIT NO. MB-1057
K881596 · Medix Biotech, Inc. · May 1988